BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that researchers have shown that Tß4 provides multi-functional protection to human gingival (gum) cells similar to its previously published activities in the eye and heart. Tß4 significantly suppressed the secretion of inflammatory cells to protect gingival cells against several known toxic agents while also preventing apoptosis (cell death).
